Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF519 (Zinc finger protein 519) is a protein-coding gene in humans encoding a predicted DNA-binding transcription factor that locates to the nucleus and is thought to regulate DNA-templated transcription. It contains C2H2-type zinc finger domains, which are classic motifs enabling sequence-specific DNA interaction and chromatin binding. While the broader zinc finger protein family participates in numerous cellular and developmental processes, the precise biological role and mechanisms of ZNF519 remain incompletely understood. Mutations in ZNF519 have been genetically linked to rare inherited disorders such as Seckel syndrome and nonsyndromic congenital nail disorder, type 4. There is no current evidence supporting a direct role in cancer or as a therapeutic target, and no drugs are known to interact with ZNF519.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 519 (ZNF519).